Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/16/2025

Treatment for 1cm Invasive Ductal Carcinoma Behind the Areola

Surgical Management

  • The European Society for Medical Oncology recommends breast-conserving surgery with sentinel lymph node biopsy followed by radiation therapy for a 1cm invasive ductal carcinoma located behind the areola, though mastectomy may be necessary due to the retro-areolar location 1, 2
  • Complete clinical staging including physical examination, full blood counts, and routine chemistry should be performed to rule out metastatic disease, as recommended by the European Society for Medical Oncology 3
  • Pathological assessment should include tumor size, grade, hormone receptor status (ER/PR), and HER2 status to guide adjuvant therapy decisions, according to the European Society for Medical Oncology 1

Adjuvant Therapy

  • The National Comprehensive Cancer Network recommends whole-breast radiation therapy to reduce local recurrence risk by approximately two-thirds if breast conservation is achieved 1, 2
  • Hypofractionated radiation therapy is preferred for most women receiving whole-breast irradiation, as recommended by the National Comprehensive Cancer Network 6
  • Adjuvant systemic therapy decisions should be based on two main factors: endocrine responsiveness of tumor tissue (ER/PR status) and risk of relapse (based on tumor size, grade, lymph node status, etc.), according to the European Society for Medical Oncology 3, 5, 1

Risk Stratification and Follow-up

  • Risk assessment should consider age, tumor size (1cm is favorable), histological grade, vascular invasion, lymph node involvement, and receptor status, as recommended by the European Society for Medical Oncology 1